CRISPR Medicine News, 19 June 2020 | New Interview: Organ-Specific In Vivo CRISPR With Cas12a Nanoclew Assemblies - CRISPR Medicine

Thank you for reading

New Interview: Organ-Specific In Vivo CRISPR With Cas12a Nanoclew Assemblies

  • New and exciting approaches to CRISPR delivery are emerging and we are delighted to bring you these updates. We recently interviewed Dr. Zhen Gu and Dr. Wujin Sun from UCLA about their newly developed bioresponsive CRISPR platform that can be programmed to efficiently deliver gene editing cargos specifically to the liver. Read the interview here.

  • In case you missed it, we wrote another piece about organ-specific gene editing a couple of weeks ago. Here, we interviewed Daniel Siegart from Texas Southwestern Medical Center. Daniel and his group are developing specialised SORT nanoparticles that have the potential to direct CRISPR and other cargos to any organ in the body. You can catch that story here.

Thank you for now - more great reads are on the way!

And if you have questions or suggestions, you can reach out to us directly at editor@crisprmedicinenews.com. We love hearing from readers!

Happy Reading!

Karen

p.s. You can follow CRISPR Medicine News on Twitter and LinkedIn. If someone forwarded this email to you, you can sign up for our newsletter yourself here.